MedPath

Effect of a Probiotic-based Product on Blood Pressure

Not Applicable
Completed
Conditions
Blood Pressure
Interventions
Other: Fermented blueberry drink
Other: Placebo drink
Other: Sachets with placebo powder
Other: Sachets with probiotic bacterial powder
Registration Number
NCT01989702
Lead Sponsor
Probi AB
Brief Summary

The aim of the present study was to examine the efficacy of a probiotic-based product on either reducing hypertension or preventing a high normal blood pressure from reaching hypertensive levels.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
142
Inclusion Criteria
  • Healthy individuals at the age of 40-75 years.
  • Blood-pressure >140/90 mmHg that has been confirmed at 2-3 separate occasions or represents the mean value of a 24-hour measurement.
  • Triglycerides >1,7 mmol/L and/or HDL <1 mmol/L (men)/1,29 mmol/L (women).
  • Fasting plasma glucose levels >5,6 mmol/L and/or waist circumference >102 cm (men)/88 cm (women).
  • BMI <40.
Exclusion Criteria
  • Medically treated allergy or allergy to any of the ingredients of the study product.
  • Medication for high levels of blood lipids.
  • Metabolic disease, such as type one diabetes.
  • Confirmed diseases of the heart, liver of kidneys.
  • Chronic inflammatory disease requiring medication.
  • Pregnant or nursing.
  • Regular intake of other probiotic products (5-7 days per week during the last three months before inclusion into the study).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Fermented blueberry productFermented blueberry drink-
Fermented blueberry productSachets with placebo powder-
PlaceboPlacebo drink-
PlaceboSachets with placebo powder-
Probiotic bacteriaPlacebo drink-
Probiotic bacteriaSachets with probiotic bacterial powder-
Primary Outcome Measures
NameTimeMethod
Changes from baseline in systolic and diastolic blood pressure after 3 months of probiotic interventionBaseline, 3 months
Secondary Outcome Measures
NameTimeMethod
Changes from baseline of blood parameters, such as inflammatory markers and blood lipids, linked to increased risk for cardiovascular diseasesBaseline, 3 months
© Copyright 2025. All Rights Reserved by MedPath